Is Awakn Life Sciences Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Awakn Life Sciences Corp (AWKN.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Awakn Life Sciences Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Awakn Life Sciences Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Awakn Life Sciences Corp?

Muslim investors may consider investing in Awakn Life Sciences Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Awakn Life Sciences Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Awakn Life Sciences Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Awakn Life Sciences Corp updated?

The Shariah compliance status of Awakn Life Sciences Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Awakn Life Sciences Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Awakn Life Sciences Corp?

You can check the latest Shariah compliance status of Awakn Life Sciences Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Awakn Life Sciences Corp. Stock Analysis AWKN.CN

Canada Health Care Nano Cap

Awakn Life Sciences Corp. is a clinical-stage biotechnology company, which engages in developing therapeutics targeting addiction. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-06-23. The firm is developing therapeutics for substance use and mental health disorders, with a near-term focus on Alcohol Use Disorder (AUD). The firm's therapeutics are focused on the brain circuits that drive addiction, multiple receptors rather than the traditional single drug receptor targets. The firm operates through three segments: development, delivery and corporate. The development segment, which focuses on researching and developing psychedelic drugs and therapies, ketamine-assisted psychotherapy and methylenedioxy-methamphetamine (MDMA)-assisted psychotherapy to treat substance and behavioral addictions. The delivery segment, which includes a chain of medical psychedelic clinics across Europe and through licensing partners. The firm operates in Ireland and Canada. The Company’s development pipeline includes AWKN-001, AWKN-002 and MDMA.

Key Statistics of Awakn Life Sciences Corp (AWKN.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.10CAD0.12

Today's Open

CAD0.11

Volume

32.41K

P/E Ratio (TTM)

52 Week Range

CAD0.10CAD0.12

Market Cap

3.96M

Avg. Volume

23.30K

Dividend Yield

Financial Metrics & Statements of Awakn Life Sciences Corp (AWKN.CN)

FAQ's for Awakn Life Sciences Corp (AWKN.CN)

According to Musaffa’s Shariah screening methodology, Awakn Life Sciences Corp (AWKN.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.